The idea of booster doses for Covid-19 vaccinations is gaining traction around the world, but India remains a skeptic. Various countries, including the United States and Israel, have approved these doses. Despite a global lack of vaccines, they were implemented…
Subscribe to our Newsletter
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
[fluentform id="3"]
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.